Keywords
paediatric population
LIGURIA
Abstract
Abstract
Introduction. This retrospective analysis aims to follow the course of SARS-CoV-2 infections in pediatric population residing in Liguria, Northwest Italy, from March 2020 to December 2022 and to relate it to the regional and national containment measures adopted, to assess the representativeness of the infection rate observed at the national level and to analyze the vaccination rates in different pediatric groups.
Methods. First episodes of SARS-CoV-2 infections registered in the national surveillance system were extracted and further anonymously analyzed for subjects aging £ 19 years. The absolute number of cases diagnosed daily during each year was compared to the number of residents in the region and graphical representations were used to visualize the trends in infection rates both annually and weekly in each year. Through narrative analysis, the relationship between changes in IR and key social events was analyzed.
Applying the direct standardization method, the epidemiology of SARS-CoV-2 infection in pediatric population was compared with that observed in the same age group in Italy.
All analyses were performed using Stata and Microsoft Excel.
Results. In the study period, 106,537 (17.4%) cases of SARS-CoV-2 infection were registered in subjects £ 19 years, out of a total of 610,404 cases reported in Liguria during that period. In the summer of 2020 the IR was close to zero, while later we observed increases and decreases in the IR in relation to activities and social restrictions adopted. Direct standardization showed an almost perfect coincidence between the expected cases in Italy, based on the Liguria incidence, and the observed cases.
Conclusions. Our results show that, in absence of effective therapies and vaccines, strict non-medical interventions (e.g. use of masks, improving indoor ventilation, physical social distancing, general lockdown) can be the only actions to counter the spread of a respiratory infection.
References
References
Garazzino S, Lo Vecchio A, Pierantoni L, Calò Carducci FI, Marchetti F, Meini A, Castagnola E, Vergine G, Donà D, Bosis S, Dodi I, Venturini E, Felici E, Giacchero R, Denina M, Pierri L, Nicolini G, Montagnani C, Krzysztofiak A, Bianchini S, Marabotto C, Tovo PA, Pruccoli G, Lanari M, Villani A, Castelli Gattinara G; Italian SITIP-SIP Pediatric Infection Study Group. Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study. Front Pediatr. 2021 Mar 16;9:649358. doi: 10.3389/fped.2021.649358. PMID: 33796491; PMCID: PMC8007917.
Castagnola E, Mariani M, Sticchi C, Sticchi L, Spiazzi R, Caorsi R, Gattorno M, Ravelli A. Incidence rate of MIS-C in paediatrics: A good reason to vaccinate children against SARS-CoV-2. Acta Paediatr. 2022 Jan;111(1):123-124. doi: 10.1111/apa.16081. Epub 2021 Sep 1. PMID: 34432905; PMCID: PMC8653129.
Bellini T, Brisca G, Mariani M, Caorsi R, Bustaffa M, Drago E, Strati MF, Piccotti E, Moscatelli A, Gattorno M, Castagnola E. Epidemiological and clinical evolution of multisystem inflammatory syndrome in children throughout the SARS-CoV-2 pandemic in a tertiary Italian children's hospital. Acta Paediatr. 2024 Mar;113(3):523-530. doi: 10.1111/apa.17054. Epub 2023 Dec 8. PMID: 38066729.
Istituto Superiore di Sanità, Sorveglianza Covid-19. Available at: https://covid-19.iss.it
Istat statistics. Available at http://dati.istat.it/Index.aspx?QueryId=18541#. Accessed on 13/01/2023
Task force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica, Istituto Superiore di Sanità. Epidemia COVID-19. National update: 28th December 2022
GitHub Open Data vaccines, available at: https://github.com/italia/covid19-opendata-vaccini. Accessed on 21/02/2024
Fathizadeh H, Afshar S, Masoudi MR, Gholizadeh P, Asgharzadeh M, Ganbarov K, Köse Ş, Yousefi M, Kafil HS. SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. Int J Biol Macromol. 2021 Oct 1;188:740-750. doi: 10.1016/j.ijbiomac.2021.08.076. Epub 2021 Aug 14. PMID: 34403674; PMCID: PMC8364403.
De Paris K, Permar SR. Routine SARS-CoV-2 vaccination for all children. Immunol Rev. 2022 Aug;309(1):90-96. doi: 10.1111/imr.13108. Epub 2022 Jul 7. PMID: 35799475; PMCID: PMC9339529.
StataCorp. Stata Statistical Software, Release 18.0, College Station, TX, USA, StataCorporation, 2023
Naeimi R, Sepidarkish M, Mollalo A, Parsa H, Mahjour S, Safarpour F, Almukhtar M, Mechaal A, Chemaitelly H, Sartip B, Marhoommirzabak E, Ardekani A, Hotez PJ, Gasser RB, Rostami A. SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis. EClinicalMedicine. 2023 Feb;56:101786. doi: 10.1016/j.eclinm.2022.101786. Epub 2022 Dec 28. PMID: 36590788; PMCID: PMC9795163.
Salmanton-García J, Wipfler P, Leckler J, Nauclér P, Mallon PW, Bruijning-Verhagen PCJL, Schmitt HJ, Bethe U, Olesen OF, Stewart FA, Albus K, Cornely OA; VACCELERATE Consortium. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics. Travel Med Infect Dis. 2024 Jan-Feb;57:102676. doi: 10.1016/j.tmaid.2023.102676. Epub 2023 Dec 6. PMID: 38061408.
Jones NR, Qureshi ZU, Temple RJ, Larwood JPJ, Greenhalgh T, Bourouiba L. Two metres or one: what is the evidence for physical distancing in covid-19? BMJ. 2020 Aug 25;370:m3223. doi: 10.1136/bmj.m3223. PMID: 32843355.
Lattanzio S. Schools and the transmission of Sars-Cov-2: Evidence from Italy. Econ Hum Biol. 2024 Jan;52:101342. doi: 10.1016/j.ehb.2023.101342. Epub 2023 Dec 13. PMID: 38104359.
Amodio E, Battisti M, Kourtellos A, Maggio G, Maida CM. Schools opening and Covid-19 diffusion: Evidence from geolocalized microdata. Eur Econ Rev. 2022 Apr;143:104003. doi: 10.1016/j.euroecorev.2021.104003. Epub 2022 Jan 19. PMID: 35075308; PMCID: PMC8769565.
García-Vera C, Castejón-Ramírez S, Laín Miranda E, Hernández Abadía R, García Ventura M, Borque Navarro E, Rubio Sánchez P, Baeta Ruiz Á, Mengual Gil JM. COVID-19 in children: clinical and epidemiological spectrum in the community. Eur J Pediatr. 2022 Mar;181(3):1235-1242. doi: 10.1007/s00431-021-04235-4. Epub 2021 Aug 18. Erratum in: Eur J Pediatr. 2022 Mar;181(3):1243-1244. doi: 10.1007/s00431-021-04253-2. PMID: 34406504; PMCID: PMC8371417.
Karki SJ, Joachim A, Heinsohn T, Lange B. Risk of infection and contribution to transmission of SARS-CoV-2 in school staff: a systematic review. BMJ Open. 2021 Nov 3;11(11):e052690. doi: 10.1136/bmjopen-2021-052690. PMID: 34732489; PMCID: PMC8572358.
Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, Li X, Xu W, Mesa-Eguiagaray I, Rostron J, Theodoratou E, Zhang X, Motee A, Liew D, Ilic D. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021 Nov 17;375:e068302. doi: 10.1136/bmj-2021-068302. Erratum in: BMJ. 2021 Dec 3;375:n2997. doi: 10.1136/bmj.n2997. PMID: 34789505; PMCID: PMC9423125.
Cowger TL, Murray EJ, Clarke J, Bassett MT, Ojikutu BO, Sánchez SM, Linos N, Hall KT. Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff. N Engl J Med. 2022 Nov 24;387(21):1935-1946. doi: 10.1056/NEJMoa2211029. Epub 2022 Nov 9. PMID: 36351262; PMCID: PMC9743802.
Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, Nair H; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021 Feb;21(2):193-202. doi: 10.1016/S1473-3099(20)30785-4. Epub 2020 Oct 22. PMID: 33729915; PMCID: PMC7581351.
Mattiuzzi C, Lippi G. Timeline analysis of clinical severity of COVID-19 in the general population. Eur J Intern Med. 2023 Apr;110:97-98. doi: 10.1016/j.ejim.2022.12.007. Epub 2022 Dec 16. PMID: 36535884; PMCID: PMC9755016.
Galmiche S, Cortier T, Charmet T, Schaeffer L, Chény O, von Platen C, Lévy A, Martin S, Omar F, David C, Mailles A, Carrat F, Cauchemez S, Fontanet A. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study. Lancet Microbe. 2023 Jun;4(6):e409-e417. doi: 10.1016/S2666-5247(23)00005-8. Epub 2023 Apr 18. PMID: 37084751; PMCID: PMC10112864.
Park SW, Sun K, Abbott S, Sender R, Bar-On YM, Weitz JS, Funk S, Grenfell BT, Backer JA, Wallinga J, Viboud C, Dushoff J. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2. Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2221887120. doi: 10.1073/pnas.2221887120. Epub 2023 May 22. PMID: 37216529; PMCID: PMC10235974.
Howard-Jones AR, Burgner DP, Crawford NW, Goeman E, Gray PE, Hsu P, Kuek S, McMullan BJ, Tosif S, Wurzel D, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, Britton PN. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J Paediatr Child Health. 2022 Jan;58(1):46-53. doi: 10.1111/jpc.15811. Epub 2021 Oct 25. PMID: 34694037; PMCID: PMC8662268.
Nguyen KH, Levisohn A, McChesney C, Vasudevan L, Bednarczyk RA, Corlin L. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents. Ann Med. 2023 Dec;55(1):2232818. doi: 10.1080/07853890.2023.2232818. PMID: 37449878; PMCID: PMC10351440.
Baysson H, Pullen N, De Mestral C, Semaani C, Pennacchio F, Zaballa ME, L'Huillier AG, Lorthe E, Guessous I, Stringhini S; Specchio-COVID19 study group. Parental willingness to have children vaccinated against COVID-19 in Geneva, Switzerland: a cross-sectional population-based study. Swiss Med Wkly. 2023 Apr 3;153(4):40049. doi: 10.57187/smw.2023.40049. PMID: 37011595.
Olick RS, Yang YT, Shaw J. When Adolescents Disagree with Their Vaccine-Hesitant Parents about COVID-19 Vaccination. J Clin Ethics. 2023 Summer;34(2):158-168. doi: 10.1086/724746. PMID: 37229735.
Rothoeft T, Brinkmann F, Maier C, Selzer D, Dings C, Kuehn A, Möhler E, Grote H, Nonnenmacher A, Wenning M, Zemlin M, Richter U, Lehr T, Lücke T. Motivations for Adolescent COVID-19 Vaccination: A Comparative Study of Adolescent and Caregiver Perspectives in Germany. Children (Basel). 2023 Dec 6;10(12):1890. doi: 10.3390/children10121890. PMID: 38136092; PMCID: PMC10742286.
Bianchi FP, Stefanizzi P, Cuscianna E, Riformato G, Di Lorenzo A, Giordano P, Germinario CA, Tafuri S. COVID-19 vaccination hesitancy among Italian parents: A systematic review and meta-analysis. Hum Vaccin Immunother. 2023 Dec 31;19(1):2171185. doi: 10.1080/21645515.2023.2171185. Epub 2023 Jan 25. PMID: 36698309; PMCID: PMC10012888.
Finney Rutten LJ, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, St Sauver JL, Virk A, Jacobson RM. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clin Proc. 2021 Mar;96(3):699-707. doi: 10.1016/j.mayocp.2020.12.024. Epub 2020 Dec 30. PMID: 33673921; PMCID: PMC7772995.